[18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer’s disease
Sandra Sanabria Bohórquez, Robby M. Weimer(Sunesis (United States)), Annie Ogasawara, Jeff N. Tinianow, Geoffrey A. Kerchner(Roche (Switzerland)), Gilles Tamagnan(Chapel Haven Schleifer Center), Michael E. Ward(National Institutes of Health), John Seibyl(Elucid Bioimaging), Herman Gill, Gai Ayalon, Jan Mařı́k(UC Davis Comprehensive Cancer Center), Paul T. Manser, Kenneth Marek(University of Pennsylvania), Thomas Bengtsson(WeMind), David Alagille(Chapel Haven Schleifer Center), Simon‐Peter Williams, Olivier Barret(Invicro (United States))
Cited by 130
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
The Parkinson Progression Marker Initiative (PPMI)
|Progress in Neurobiology|2011|1.9k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
|Movement Disorders|2017|846
Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes
|Proceedings of the National Academy of Sciences|2010|666